BTO Pharm

BTO Pharm is a South Korean biotechnology company specializing in the development of advanced transdermal drug delivery systems (TDDS). The company focuses on converting oral medications into patch formulations to improve patient compliance and reduce side effects, particularly for chronic conditions. Their lead programs include a donepezil patch for Alzheimer's disease and various treatments for pain management. BTO Pharm leverages its proprietary formulation technology to optimize skin permeability and drug stability. The company aims to expand its portfolio into global markets through strategic partnerships and clinical validation of its delivery platforms.